Respiratory monitoring for the detection of opioid induced ventilation impairment
About PneuMotion
Adverse opioid events can cause significant injury or death and are associated with greater hospital costs. Reducing or eliminating these events requires continuous respiratory monitoring. PneuMotion provides continuous respiratory rate monitoring and obstructive apnea detection. PneuMotion seamlessly integrates into a hospital's existing network and allows mobile respiratory monitoring and EHR data collection. Ultra-low cost sensor technology makes this a cost-effective solution for opioid safety.
27 Million
Patients receiving opioid pain medications each year
$7 Billion
Healthcare costs related to respiratory insufficiency, arrest
$4 Million
Average malpractice settlement involving sleep apnea and adverse opioid events
Hospital Respiratory Monitoring
Home Overdose Monitoring
MedTech Innovator's top 100 companies for 2017